Lund University and Skåne University Hospital in Malmö, Sweden. Jan Astermark is Professor in Clinical Coagulation Medicine at Lund University, Senior Consultant and Director of the Center for Thrombosis and Hemostasis in Malmö and Assistant Head of the Department of Translational Medicine in Malmö/Lund, Sweden. He is a specialist in haematology, coagulation disorders and internal medicine. He is a reviewer for haematology journals, and has published a number of original articles, review articles and book chapters in the field of haemophilia and coagulation disorders.
Bayer, CSL Behring, Novo Nordisk, Octopharma, Roche, Sobi and Takeda/Shire.
Prof. Jan Astermark and Dr. Katharina Holstein discuss their views on the use of ITI in haemophilia